National Health Investors (NYSE:NHI) cut to sell at Zacks Investment Research
National Health Investors (NYSE: NHI – Get a Grade) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note released Thursday, Zacks.com reports.
According to Zacks, “National Health Investors, Inc. is a real estate investment trust that invests in income-generating healthcare properties, primarily in the long-term care sector. The company provides current income for distribution to shareholders through through investments in healthcare-related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities.”
Several other research companies also commented on INSA. BMO Capital Markets upgraded National Health Investors shares from a “market performance” rating to an “outperform” rating and set a price target of $68.00 for the company in a research report by the Friday, January 7. Credit Suisse Group launched coverage on National Health Investors in a Tuesday, Feb. 1 research note. They set an “underperforming” rating and a price target of $51.00 for the company. Two investment analysts have assigned a sell rating to the stock, two have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, National Health Investors has an average rating of “Hold” and a consensus price target of $66.40.
NHI stock opened at $57.10 on Thursday. The company has a debt ratio of 0.82, a current ratio of 18.70 and a quick ratio of 18.70. National Health Investors has a one-year low of $50.88 and a one-year high of $76.81. The company’s 50-day simple moving average is $56.46. The stock has a market capitalization of $2.62 billion, a P/E ratio of 23.40 and a beta of 0.93.
National Health Investors (NYSE:NHI – Get Rating) last released quarterly results on Tuesday, February 22. The real estate investment trust reported earnings per share of $0.14 for the quarter, missing the consensus estimate of $1.05 per ($0.91). The company posted revenue of $69.67 million in the quarter, versus a consensus estimate of $67.14 million. National Health Investors posted a net margin of 37.43% and a return on equity of 7.23%. The company’s revenue was down 14.2% year over year. In the same quarter last year, the company achieved EPS of $1.37. As a group, stock analysts expect National Health Investors to post EPS of 4.63 for the current fiscal year.
A number of hedge funds have recently bought and sold shares of the company. BlackRock Inc. increased its holdings of National Health Investors shares by 3.3% during the 4th quarter. BlackRock Inc. now owns 4,539,322 shares of the real estate investment trust worth $260,874,000 after acquiring an additional 145,018 shares in the last quarter. State Street Corp increased its holdings of National Health Investors stock by 7.4% during the 4th quarter. State Street Corp now owns 1,886,457 shares of the real estate investment trust worth $110,094,000 after acquiring an additional 130,364 shares last quarter. Goldman Sachs Group Inc. increased its stake in National Health Investors by 2.7% during the third quarter. Goldman Sachs Group Inc. now owns 1,085,258 shares of the real estate investment trust valued at $58,062,000 after purchasing an additional 28,172 shares during the period. Macquarie Group Ltd. increased its stake in National Health Investors by 14.9% during the third quarter. Macquarie Group Ltd. now owns 999,755 shares of the real estate investment trust valued at $53,487,000 after purchasing an additional 129,269 shares during the period. Finally, Lasalle Investment Management Securities LLC increased its stake in National Health Investors by 66.4% during the 4th quarter. Lasalle Investment Management Securities LLC now owns 941,562 shares of the real estate investment trust valued at $54,112,000 after purchasing an additional 375,566 shares during the period. Institutional investors and hedge funds hold 63.34% of the company’s shares.
About National Health Investors (Get a rating)
National Health Investors, Inc is a real estate investment trust engaged in sale-leaseback, joint venture, mortgage, and mezzanine financing of senior housing and medical investments. Its portfolio includes investments in leases, mortgages and other notes in independent living facilities, assisted living facilities, fee-paying communities, seniors’ residences, skilled nursing facilities, specialty hospitals and medical office buildings.
Get a Free Copy of Zacks National Health Investors (NHI) Research Report
For more information on Zacks Investment Research’s research offerings, visit Zacks.com
This instant alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]
Should you invest $1,000 in National Health Investors right now?
Before you consider National Health Investors, you’ll want to hear this.
MarketBeat tracks Wall Street’s top-rated, top-performing research analysts daily and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market takes off…and National Health Investors was not on the list.
While National Health Investors currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
See the 5 actions here